|
(P1078) |
Insulin-like growth factor 1, but not insulin, induces an anti-inflammatory neutrophil phenotype |
| |
|
S. Reidel, R. Nederlof, P. Petzsch, K. Köhrer, A. Gödecke (Düsseldorf) |
|
(P1079) |
Specific Ceramide Synthase 2 overexpression leads to increased proinflammatory ceramides and subsequently impairs mitochondrial function leading to cell death |
| |
|
T. Kretzschmar, M. ELsaied, D. Haase, J. Wu, T. Müller, M. Gräler, S. Nietzsche, C. Schulze (Jena) |
|
(P1080) |
Hypertrophy, immune cell infiltration and fibrosis of the superior cervical ganglion in early stages of myocardial disease |
| |
|
K. Ziegler, A. Dueck, D. Esfandyari Shahvar, I. Sinicina, M. Graw, A. Lang, T. Misgeld, S. Engelhardt (München) |
|
(P1081) |
The endocannabinoid Anandamide mediates anti-inflammatory effect by activating NR4A nuclear receptors |
| |
|
B. Pflüger-Müller, R. P. Brandes (Frankfurt am Main) |
|
(P1082) |
T cell-derived adenosine controls IL-6 production in the infarcted heart by Gq-mediated activation of cardiac stromal cells |
| |
|
C. Alter, S. Henseler, Z. Ding, C. Owenier, J. Hesse, J. Scheller, J. Schrader (Düsseldorf) |
|
(P1083) |
MPO-mediated monocyte and macrophage activation in myocardial infarction |
| |
|
V. Peters, I. Erdmann, B. Arand, D. Mehrkens, S. Geissen, D. Muders, F. Nettersheim, D. Bachurski, H. Hansen, V. Rudolph, A. Klinke, H. Winkels, M. Adam, S. Baldus, M. Mollenhauer, for the study group: Experimentelle Kardiologie (Köln, Bad Oeynhausen) |
|
(P1084) |
ADAM10 controls post-infarction cardiac function and survival via regulation of the NLRP3 inflammasome |
| |
|
E. Klapproth, S. Künzel, M. Günscht, K. Lorenz, S. Weber, K. Guan, A. El-Armouche (Dresden, Würzburg) |
|
(P1085) |
Telomere shortening in heart failure induced by excess neurohormonal activation is caused by myocardial inflammation and increased ROS leading to increased DNA-damage and determines cardiac recovery |
| |
|
M. Brandt, H. Dörschmann, S. Kalinovic, A. Daiber, T. Münzel, P. Wenzel (Mainz) |
|
(P1086) |
Pleiotropic effects of NO2OA alleviate dilated cardiomyopathy in the MLP-/- mouse model |
| |
|
W. Schumacher, S. Braumann, F. Nettersheim, D. Mehrkens, S. Geissen, V. Rudolph, A. Klinke, M. Adam, M. Mollenhauer, S. Baldus (Köln, Bad Oeynhausen) |
